Based in Gembloux at Créalys Science Park, Volition is a multinational life-sciences company developing simple and easy tests for the accurate diagnosis of many forms of cancer. The tests are founded on the science of Nucleosomics®, detecting the presence of possible disease.
Volition’s research and development activities are currently centred in Belgium (approximately 40 staff), with additional offices in the United Kingdom, United States and Asia, while the company focuses on commercialising its diagnostic products primarily in Europe, then in the US and ultimately worldwide. Volition has just invested in a second building in Créalys Park, to set up its production activities. Its products will be distributed globally.
Volition is a world leader in circulating chromatin technology and is commencing clinical development of some of these technologies for diseases associated with NETosis. The clinical technologies include therapeutic antibody development as well as other technologies.
In the context of its expansion, Volition requires the services of a:
Clinical Development Project Manager for Novel Therapies in Sepsis, COVID-19 and other NETosis associated diseases
You will be responsible for overseeing and guiding multiple clinical studies (phases I-III), for multiple products and disease areas, overseeing outsourced partners, as well as review and assessment of the work performed, compliance, risks and bottlenecks.
Specific tasks include :
Apply now by clicking on the Apply now button.
Ref. 545-010 (2021)
Your application will be processed quickly and in confidence. habeas is managing this assignment exclusively.